Paul G. Murray

7.6k total citations · 2 hit papers
92 papers, 5.4k citations indexed

About

Paul G. Murray is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Paul G. Murray has authored 92 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Oncology, 41 papers in Pathology and Forensic Medicine and 29 papers in Immunology. Recurrent topics in Paul G. Murray's work include Viral-associated cancers and disorders (48 papers), Lymphoma Diagnosis and Treatment (41 papers) and Immune Cell Function and Interaction (21 papers). Paul G. Murray is often cited by papers focused on Viral-associated cancers and disorders (48 papers), Lymphoma Diagnosis and Treatment (41 papers) and Immune Cell Function and Interaction (21 papers). Paul G. Murray collaborates with scholars based in United Kingdom, United States and Hong Kong. Paul G. Murray's co-authors include Lawrence S. Young, Lee Fah Yap, Qian Tao, Wenbin Wei, Richard F. Ambinder, Martina Vockerodt, Katerina Vrzalikova, Gopesh Srivastava, Jianming Ying and Ciarán Woodman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Communications.

In The Last Decade

Paul G. Murray

91 papers receiving 5.3k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epstein–Barr virus: more than 50 years old and still providing surprises

2016 588 citations Lawrence S. Young, Lee Fah Yap et al. profile →
HIF activation identifies early lesions in VHL kidneys

2002 398 citations Paul G. Murray et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul G. Murray United Kingdom	39	2.9k	2.0k	1.5k	1.1k	1.1k	92	5.4k
Lorenzo Leoncini Italy	40	2.7k 0.9×	1.7k 0.9×	2.5k 1.7×	922 0.8×	870 0.8×	221	5.6k
Jean Soulier France	51	3.8k 1.3×	4.1k 2.0×	1.5k 1.0×	1.3k 1.1×	1.0k 1.0×	155	9.2k
Enrique A. Mesri United States	30	3.1k 1.1×	1.7k 0.9×	930 0.6×	1.3k 1.1×	549 0.5×	60	5.5k
Alfred C. Feller Germany	44	2.7k 0.9×	1.7k 0.8×	3.5k 2.4×	2.8k 2.4×	919 0.9×	167	8.0k
Éric Delabesse France	38	1.0k 0.4×	2.5k 1.2×	943 0.6×	853 0.8×	678 0.6×	156	7.1k
Elizabeth Hyjek United States	29	1.8k 0.6×	1.1k 0.5×	671 0.5×	799 0.7×	425 0.4×	68	3.6k
David Reisman United States	37	2.5k 0.8×	3.8k 1.9×	1.6k 1.1×	634 0.6×	652 0.6×	93	5.9k
Pier Paolo Piccaluga Italy	40	2.1k 0.7×	1.3k 0.6×	2.7k 1.9×	1.4k 1.2×	438 0.4×	208	5.8k
Mariusz A. Wasik United States	55	4.9k 1.7×	3.2k 1.6×	3.0k 2.1×	3.4k 3.0×	696 0.7×	187	10.4k
Kimberly E. Foreman United States	29	1.7k 0.6×	1.8k 0.9×	346 0.2×	681 0.6×	738 0.7×	56	3.8k

Countries citing papers authored by Paul G. Murray

Since Specialization

Citations

This map shows the geographic impact of Paul G. Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul G. Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul G. Murray more than expected).

Fields of papers citing papers by Paul G. Murray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul G. Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul G. Murray. The network helps show where Paul G. Murray may publish in the future.

Co-authorship network of co-authors of Paul G. Murray

This figure shows the co-authorship network connecting the top 25 collaborators of Paul G. Murray. A scholar is included among the top collaborators of Paul G. Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul G. Murray. Paul G. Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Perry, Tracey, Katerina Vrzalikova, Matthew Pugh, et al.. (2024). The Oncogenic Lipid Sphingosine-1-Phosphate Impedes the Phagocytosis of Tumor Cells by M1 Macrophages in Diffuse Large B Cell Lymphoma. Cancers. 16(3). 574–574. 5 indexed citations

Vrzalikova, Katerina, Lucia Mundo, Stefano Lazzi, et al.. (2023). Epstein–Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma. Life. 13(2). 521–521. 15 indexed citations

Khan, Abdullah O., Jasmeet S. Reyat, Joshua H. Bourne, et al.. (2022). Preferential uptake of SARS-CoV-2 by pericytes potentiates vascular damage and permeability in an organoid model of the microvasculature. Cardiovascular Research. 118(15). 3085–3096. 20 indexed citations

Berditchevski, Fedor, et al.. (2021). Calcium-dependent signalling in B-cell lymphomas. Oncogene. 40(45). 6321–6328. 6 indexed citations

Notarte, Kin Israel, et al.. (2021). MicroRNA and Other Non-Coding RNAs in Epstein–Barr Virus-Associated Cancers. Cancers. 13(15). 3909–3909. 31 indexed citations

Tan, May, Max Robinson, Maha Ibrahim, et al.. (2019). Collagen Induces a More Proliferative, Migratory and Chemoresistant Phenotype in Head and Neck Cancer via DDR1. Cancers. 11(11). 1766–1766. 43 indexed citations

Wei, Wenbin, et al.. (2018). Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma. Head & Neck. 41(4). 993–1006. 28 indexed citations

Li, Lili, Brigette Ma, Anthony T.�C. Chan, et al.. (2018). Epstein-Barr Virus-Induced Epigenetic Pathogenesis of Viral-Associated Lymphoepithelioma-Like Carcinomas and Natural Killer/T-Cell Lymphomas. Pathogens. 7(3). 63–63. 19 indexed citations

Vrzalikova, Katerina, Taofik O. Sunmonu, Gary Reynolds, & Paul G. Murray. (2018). Contribution of Epstein–Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma. Pathogens. 7(3). 59–59. 19 indexed citations

10.

Wragg, Joseph W., Jane Anderson, Henry J.M. Ferguson, et al.. (2016). MCAM and LAMA4 Are Highly Enriched in Tumor Blood Vessels of Renal Cell Carcinoma and Predict Patient Outcome. Cancer Research. 76(8). 2314–2326. 53 indexed citations

11.

Palser, Anne, Nicholas Grayson, Robert E. White, et al.. (2015). Genome Diversity of Epstein-Barr Virus from Multiple Tumor Types and Normal Infection. Journal of Virology. 89(10). 5222–5237. 187 indexed citations

12.

Murray, Paul G. & Andrew Bell. (2015). Contribution of the Epstein-Barr Virus to the Pathogenesis of Hodgkin Lymphoma. Current topics in microbiology and immunology. 390(Pt 1). 287–313. 11 indexed citations

13.

Vockerodt, Martina, Lee Fah Yap, Claire Shannon‐Lowe, et al.. (2014). The Epstein–Barr virus and the pathogenesis of lymphoma. The Journal of Pathology. 235(2). 312–322. 170 indexed citations

14.

Loreto, Carla Di, Fabio Puglisi, Paul G. Murray, et al.. (2012). Thymidine phosphorylase expression in metastatic kidney cancer as a potential predictor of outcome in patients treated with sunitinib.. Journal of Clinical Oncology. 30(15_suppl). e15091–e15091. 2 indexed citations

15.

Ying, Jianming, Hongyu Li, Paul G. Murray, et al.. (2007). Tumor-Specific Methylation of the 8p22 Tumor Suppressor Gene DLC1 is an Epigenetic Biomarker for Hodgkin, Nasal NK/T-Cell and Other Types of Lymphomas. Epigenetics. 2(1). 15–21. 22 indexed citations

16.

Young, Lawrence S., et al.. (2006). The role of cellular flice inhibitory protein (c-FLIP) in the pathogenesis and treatment of cancer. Expert Opinion on Therapeutic Targets. 10(1). 27–35. 43 indexed citations

17.

Murray, Paul G., Guo‐Hua Qiu, Li Fu, et al.. (2004). Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma. Oncogene. 23(6). 1326–1331. 49 indexed citations

18.

Murray, Paul G. & Lawrence S. Young. (2001). Epstein–Barr virus infection: basis of malignancy and potential for therapy. Expert Reviews in Molecular Medicine. 3(28). 1–20. 47 indexed citations

19.

Keates, Sarah, Andrew C. Keates, Michel Warny, et al.. (1999). Differential Activation of Mitogen-Activated Protein Kinases in AGS Gastric Epithelial Cells by cag + and cag − Helicobacter pylori. The Journal of Immunology. 163(10). 5552–5559. 235 indexed citations

20.

Flavell, K J, Christothea M. Constandinou, D. Lowe, et al.. (1999). Effect of material deprivation on Epstein–Barr virus infection in Hodgkin’s disease in the West Midlands. British Journal of Cancer. 80(3-4). 604–608. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact